NYLIM U.S. Large Cap R&D Leaders ETF
LRND · ETF
About LRND
- Issuer
- NYLIM
- Tracks
- NYLIM U.S. Large Cap R&D Leaders Index - USD - Benchmark TR Gross
- Expense ratio
- 0.14%
- Assets under management
- $447.53M
- Inception
- Feb 8, 2022
- Asset class
- Equity
- Website
- nylim.com
LRND key statistics
- Market cap
- 0
- Price-earnings ratio
- 0.00
- Average volume
- 25.79K
- Volume
- 5.80K
- Open price
- $45.98
- High today
- $46.11
- Low today
- $45.98
- 52 Week high
- $49.31
- 52 Week low
- $35.87
NYLIM U.S. Large Cap R&D Leaders ETF (LRND) at a glance
As of Oct 23, 2026, NYLIM U.S. Large Cap R&D Leaders ETF (LRND) shares are priced at $46.00, giving the company a market cap of 0 and a price-to-earnings ratio of 0.00.
Today the fund has traded between $45.98 and $46.11. The current price is 0.0% above the day's low and 0.2% below its high.
Volume so far is 5.80K shares, below the average of 25.79K shares a day.
Over the past year NYLIM U.S. Large Cap R&D Leaders ETF has ranged from $35.87 to $49.31, and now sits 75% of the way up that range.
LRND news
- Anusuya Lahiri
- Anusuya Lahiri
Can John Ternus Bring Steve Jobs-Style Innovation Back to Apple?
- Anusuya Lahiri
Global Phone Shipments Drop, but Apple Positioned for Record iOS Market Share Gain
- Anusuya Lahiri
iPhone Buyers Rush in Before Potential Apple Price Increases
- Piero Cingari
Alphabet's Earnings Rally Pushes Magnificent 7 Market Cap To Record $16.8 Trillion: 10 Tech-Heavy ETFs Moving Wednesday
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.